Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT05980936

Screening for Obstructive Sleep Apnea in Medical Patients

Screening for Obstructive Sleep Apnea in the General Medical Ward in Tertiary Care Centers in the Middle East

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Jordan Collaborating Cardiology Group · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Obstructive sleep apnea (OSA) is highly prevalent in the general population and is associated with multiple adverse cardiovascular consequences. Screening for OSA is recommended in those with typical symptoms, such as daytime sleepiness, loud snoring, or abrupt awakenings with gasping or choking. Patients admitted to the general medical wards with these symptoms will be evaluated for the possibility of having OSA.

Detailed description

Obstructive sleep apnea (OSA) is a disease that is highly prevalent in all communities and is associated with adverse cardiovascular events. Screening for OSA is recommended in men and women who have the typical symptoms, including snoring, daytime sleepiness, or abrupt awakenings with choking or gasping. OSA screening is also recommended for those with resistant hypertension, bradyarrhythmias, and atrial fibrillation. Heart failure patients should also be screened for OSA. It is very important to increase the use of OSA screening especially in patients admitted to the medical floor in tertiary care hospitals. No study has evaluated this topic in the Middle East in the past.

Conditions

Interventions

TypeNameDescription
OTHERScreening for obstructive sleep apneaPatient will be interviewed and asked of there are symptoms of snoring, day somnolence, chocking or gasping during sleep

Timeline

Start date
2023-10-15
Primary completion
2025-02-15
Completion
2025-02-22
First posted
2023-08-08
Last updated
2025-02-25

Locations

2 sites across 1 country: Jordan

Source: ClinicalTrials.gov record NCT05980936. Inclusion in this directory is not an endorsement.